Title : Ovarian Cancer Vaccine
link : Ovarian Cancer Vaccine
Ovarian Cancer Vaccine
Personalized cancer vaccine for ovarian cancer; abstract:
We conducted a pilot clinical trial testing a personalized vaccine generated by autologous dendritic cells (DCs) pulsed with oxidized autologous whole-tumor cell lysate (OCDC), which was injected intranodally in platinum-treated, immunotherapy-naïve, recurrent ovarian cancer patients. OCDC was administered alone (cohort 1, n = 5), in combination with bevacizumab (cohort 2, n = 10), or bevacizumab plus low-dose intravenous cyclophosphamide (cohort 3, n = 10) until disease progression or vaccine exhaustion. A total of 392 vaccine doses were administered without serious adverse events. Vaccination induced T cell responses to autologous tumor antigen, which were associated with significantly prolonged survival. Vaccination also amplified T cell responses against mutated neoepitopes derived from nonsynonymous somatic tumor mutations, and this included priming of T cells against previously unrecognized neoepitopes, as well as novel T cell clones of markedly higher avidity against previously recognized neoepitopes. We conclude that the use of oxidized whole-tumor lysate DC vaccine is safe and effective in eliciting a broad antitumor immunity, including private neoantigens, and warrants further clinical testing.
Thus Article Ovarian Cancer Vaccine
That's an article Ovarian Cancer Vaccine This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Ovarian Cancer Vaccine with the link address https://letslifes.blogspot.com/2018/05/ovarian-cancer-vaccine.html
0 Response to "Ovarian Cancer Vaccine"
Post a Comment